Nesina and Neoral drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nesina (alogliptin benzoate) and Neoral (cyclosporine). Common drug interactions include anaemia among females and platelet count decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Nesina and Neoral. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Nesina?

Nesina has active ingredients of alogliptin benzoate. eHealthMe is studying from 2,297 Nesina users. Check the latest studies of Nesina.

What is Neoral?

Neoral has active ingredients of cyclosporine. It is often used in psoriasis. eHealthMe is studying from 26,084 Neoral users. Check the latest studies of Neoral.



On Jul, 21, 2026

14 people who take Nesina and Neoral together, and have interactions are studied.

Nesina and Neoral drug interactions.

What are the common drug interactions of Nesina and Neoral, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Decreased appetite
  3. Infection
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
  6. Sudden death
  7. Liver disorder (liver diseases)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Renal impairment (severely reduced kidney function)
  10. Cardiac failure

male:

  1. Platelet count decreased
  2. Blood creatinine increased
  3. Oedema (fluid collection in tissue)
  4. Oedema peripheral (superficial swelling)
  5. Ventricular fibrillation (abnormally irregular heart rhythm)
  6. White blood cell count decreased
  7. Renal impairment (severely reduced kidney function)
  8. Acute myocardial infarction (acute heart attack)
  9. Anaemia (lack of blood)
  10. Constipation

What are the common drug interactions of Nesina and Neoral, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Anaemia (lack of blood)
  2. Constipation
  3. Hyperglycaemia (high blood sugar)
  4. Hypotension (abnormally low blood pressure)
  5. Lymphocyte count decreased
  6. Oedema (fluid collection in tissue)
  7. Oedema peripheral (superficial swelling)
  8. Platelet count decreased
  9. White blood cell count decreased

60+:

  1. Renal impairment (severely reduced kidney function)
  2. Blood creatinine increased
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Acute myocardial infarction (acute heart attack)
  5. Cardiac failure
  6. Cardiac ventricular thrombosis (blood clot in ventricle)
  7. Cerebral infarction (less blood supply to brain resulting tissue damage)
  8. Gamma-glutamyltransferase increased
  9. Interstitial lung disease
  10. Intracardiac thrombus (presence of a circumscribed mass with heart wall)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 35.71%
  2. Diabetes: 4 people, 28.57%
  3. Aplastic Anemia: 4 people, 28.57%
  4. Right Ventricular Failure (right half of the heart fails to work): 2 people, 14.29%
  5. Polymyositis (inflammatory muscle disease that causes weakness of the skeletal muscles): 2 people, 14.29%
  6. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 14.29%
  7. Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 14.29%
  8. Hepatitis C: 2 people, 14.29%
  9. Gastric Ulcer (stomach ulcer): 2 people, 14.29%
  10. Type 2 Diabetes: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Nesina and Neoral?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nesina and Neoral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nesina:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Neoral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nesina and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Neoral and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on alogliptin benzoate and cyclosporine (the active ingredients of Nesina and Neoral, respectively), and Nesina and Neoral (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: